Coexpression of erythropoietin and erythropoietin receptor in Von Hippel-Lindau disease - Associated renal cysts and renal cell carcinoma

57Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Von Hippel-Lindau (VHL) disease is characterized by multiple tumors in specific target organs. The tumors at different sites share distinct morphologic and genetic characteristics but their cell of origin is unknown. We show that VHL disease-associated renal clear cell carcinomas (RCC) consistently coexpress erythropoietin (Epo) and Epo receptor (EpoR). In addition, coexpression of Epo and EpoR is detected in many renal cysts, providing further evidence that renal cysts are potential precursors for RCC. In conjunction with VHL gene deficiency, coexpression of Epo and EpoR in renal cysts and tumors may reflect a developmental arrest in immature mesenchymal cells. Such arrest may lead to autocrine stimulation, cell proliferation, and renal tumor development, similar to tumorigenesis of VHL disease - associated hemangioblastomas.

Cite

CITATION STYLE

APA

Lee, Y. S., Vortmeyer, A. O., Lubensky, I. A., Vogel, T. W. A., Ikejiri, B., Ferlicot, S., … Zhuang, Z. (2005). Coexpression of erythropoietin and erythropoietin receptor in Von Hippel-Lindau disease - Associated renal cysts and renal cell carcinoma. Clinical Cancer Research, 11(3), 1059–1064. https://doi.org/10.1158/1078-0432.1059.11.3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free